September 5, 2026

Every few years, the bio-based chemicals sector seems to produce a fresh “valley of death” peaks. The pattern maintains with companies with promising technologies, patient capital that eventually becomes impatient, difficult first plants, slow customer adoption, and then the inevitable round of exits, sales, shutdowns, bankruptcies and restructurings. This slide is part of a presentation…